Takeda’s late-phase epilepsy program has failed a key test, chalking up misses on the primary endpoints in pivotal trials in two indications. But the Japanese drugmaker still plans to talk to ...

Epilepsy is already represented in Jazz Pharmaceuticals’ portfolio by Epidiolex, a drug that treats seizures caused by three rare types of this brain disorder. Epilepsies have many drivers, and Jazz ...

Autoimmune epilepsy is a newly defined group of conditions characterized by recurrent seizures associated with autoimmunity. Cancer and infections are two potential triggers. Epilepsy is a seizure ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible for drug-resistant epilepsy. Surgery can be a life-changing option for ...

A new clinical trial co-led by researchers at FutureNeuro and RCSI University of Medicine and Health Sciences is investigating how advanced brain monitoring could improve the diagnosis and management ...

Oregon paramedics will start testing a drug that could some day let people treat long, dangerous seizures even before an ambulance arrives. If the test works, it could give a new anti-seizure tool not ...

Epilepsy presents differently in each person. The condition has a range of symptoms that varies. Convulsions can be one sign of epilepsy. However, people often experience epilepsy without ever having ...